/
AYTU
$2.30-$0.06 (-2.54%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$25.3M
11M shares
52-week range
$1.65 – $3.07
46% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
CS
Change$-63.70
AYTU BioPharma, Inc. Common Stock
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.
www.aytubio.com- Employees
- 83
- IPO / List date
- Feb 15, 2008
- HQ
- DENVER, CO
Held by traders on TradeandTell
No one on the platform currently holds AYTU.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 93,723 | $255.9K |
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2023-01-06 | 1-for-20reverse |
| 2020-12-09 | 1-for-10reverse |
| 2018-08-13 | 1-for-20reverse |
| 2017-08-29 | 1-for-20reverse |
| 2016-07-01 | 1-for-12reverse |
Recent trades on TradeandTell
No one on the platform has traded AYTU yet.
